ViroMissile, Inc. — Form D/A
ViroMissile, Inc. of LA JOLLA, CA, a company, filed a Form D amendment with the SEC on 2025-06-06. The offering totals $15.0M, of which $500K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-06-06
- Form: D/A
- Accession: 0001974798-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $500K
- Remaining: $14.5M
- Minimum investment: $100K
- Investors: 5
- Date of first sale: 2025-03-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-541398
Issuer
- Name: ViroMissile, Inc.
- CIK: 0001974798
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 505 COAST BLVD SOUTH, SUITE 208, LA JOLLA, CA, 92037
- Phone: (858) 886-7718
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Rolf G Benirschke | Director | La Jolla, CA |
| Mark G Bertagnolli | Director | La Jolla, CA |
| Nanhai G Chen | Director | La Jolla, CA |
| Douglas G Wall | Director | La Jolla, CA |
| Tianyu G Zhou | Director | La Jolla, CA |
| Mark G Bertagnolli | Executive Officer | La Jolla, CA |
| Nanhai G Chen | Executive Officer | La Jolla, CA |
| Weili G Zhou | Director | La Jolla, CA |
Other filings by this issuer (3)
More